Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lacrimal punctum is a minute anatomical opening located on the medial aspect of the eyelid margin, specifically at the apex of the lacrimal papilla. It functions as the entry point for the nasolacrimal drainage system, collecting tears from the ocular surface and directing them into the lacrimal canaliculi (StatPearls, 2023). While not a molecular drug target like a receptor or enzyme, the punctum is a critical site for mechanical therapeutic interventions, particularly in the management of chronic dry eye disease. Procedures such as punctal occlusion using collagen or silicone plugs are employed to reduce tear drainage and increase the residence time of the tear film on the eye (American Academy of Ophthalmology, 2023). Conversely, punctal stenosis or obstruction can lead to epiphora, necessitating surgical dilation or punctoplasty. Therefore, while it lacks classical pharmacological interactions, its structural integrity and patency are vital for ocular health and the efficacy of topical ophthalmic treatments.
Not applicable (Physical intervention site for occlusion or dilation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lacrimal punctum.